Grifols (GRFS) Net Margin (2010 - 2019)
Grifols (GRFS) reported Net Margin of 17.91% for Q4 2019, up 20.89% quarter-over-quarter from 14.82% in Q1 2019.
Grifols (GRFS) Net Margin (2010 - 2019) Analysis & Trends
Grifols has reported Net Margin for 9 years, with the latest figure at 17.91% in Q4 2019.
- For the quarter ending Q4 2019, Net Margin changed N/A year-over-year to 17.91%; the trailing twelve-month figure through Dec 2019 stood at 21.68% (changed N/A YoY), and the FY2025 full-year result was 5.34%, down 7605.0% from the prior year.
- Net Margin for Q4 2019 stood at 17.91%, up from 14.82% in the prior quarter.
- The five-year high for Net Margin was 40.61% in Q3 2016, with the low at 0.01% in Q2 2015.
- Historically, Net Margin has averaged 16.88% across 5 years, with a median of 15.41% in 2018.
- Annual changes were most pronounced in 2016 — Net Margin surged 2618 bps — and 2019, when it sank 620 bps.
- Grifols' Net Margin stood at 12.28% in 2015, then increased by 3 bps to 12.69% in 2016, then surged by 62 bps to 20.52% in 2017, then retreated by 22 bps to 16.0% in 2018, then rose by 12 bps to 17.91% in 2019.
- The last three Net Margin figures came in at 17.91% (Q4 2019), 14.82% (Q1 2019), and 16.0% (Q2 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | 22.77% |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 37.36% |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 21.76% |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 4.65% |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | -25.84% |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 21.11% |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 29.04% |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | -0.56% |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 23.32% |
| 10 | Grifols | 6.05 Bn | 5.09 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 17.91% |
| Mar 31, 2019 | 14.82% |
| Jun 30, 2018 | 16.00% |
| Mar 31, 2018 | 21.02% |
| Jun 30, 2017 | 20.52% |
| Dec 31, 2016 | 12.69% |
| Sep 30, 2016 | 40.61% |
| Jun 30, 2016 | 18.08% |
| Dec 31, 2015 | 12.28% |
| Sep 30, 2015 | 14.43% |
| Jun 30, 2015 | 0.01% |
| Mar 31, 2015 | 14.14% |
| Sep 30, 2013 | 12.65% |
| Jun 30, 2013 | 13.17% |
| Mar 31, 2013 | 13.31% |
| Dec 31, 2012 | 17.28% |
| Sep 30, 2012 | 9.93% |
| Jun 30, 2012 | 10.15% |
| Mar 31, 2012 | 10.13% |
| Dec 31, 2011 | 1.10% |